AzTrials
AzTrials

Dental PlaqueNCT05946473

Development of a Novel Anti-caries Chewing Gum

A study testing Gum base containing xylitol and essencial oils and Gum base with no additives in people with Dental Plaque and Dental Caries, run by University of Toronto.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This research study is designed to evaluate the chewing gum's ability to modulate the oral microbiome in human participants, in addition to its safety. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Dental Plaque, Dental Caries, Periodontal Disease
What is being tested?
Gum base containing xylitol and essencial oils and Gum base with no additives
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
No sites listed yet
Study dates
Jul 2023to Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • In good general health, no relevant medical history
  • No dental treatment in the previous 3 months
  • Willing to participate and give written informed consent

Who cannot join

  • Patients undergoing fixed or removable orthodontic treatment
  • Patients using removable prosthesis
  • History of head and neck radiation therapy
  • History of adverse reaction or allergies to xylitol or other additives
  • Antibiotics use in the last four weeks
  • Patients with any systemic diseases
Show all 10Show fewer
  • Xerostomia (also medication-induced)
  • Smokers
  • Currently using any mouth rinse
  • Pregnant or breastfeeding women

About this study

This research study is designed to evaluate the chewing gum's ability to modulate the oral microbiome in human participants, in addition to its safety.

Read the detailed description

The goal of this project is to develop a pre-biotic chewing gum that is designed to promote a healthy oral microbiome. The gum will contain compounds that will: a) be unable to be converted to acids; b) target the cariogenic S. mutans population; c) promote the stability of a healthy environment by modulating plaque pH via base-generating compounds; d) promote tooth remineralization by increasing saliva flow and by addition of calcium phosphate.

Being tested
Gum base containing xylitol and essencial oils, Gum base with no additives
Medical subject headings
Dental Plaque, Dental Caries, Periodontal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gum base containing xylitol and essencial oilsDietary supplement

    Participants will be asked to chew 2 pieces of chewing gum containing additives for 10 minutes after eating in the morning, and after one meal in the evening, for a four-week period

  • Gum base with no additivesDietary supplement

    Participants will be asked to chew 2 pieces of pure gum base for 10 minutes after eating in the morning, and after one meal in the evening, for a four-week period

Study groups in NCT05946473
Study groupRoleWhat they receive
Experimental gum formulationExperimentalParticipants will be asked to chew 2 pieces of chewing gum containing additives 2 times a day for a four-week period
Receives: Dietary Supplement: Gum base containing xylitol and essencial oils
PlaceboPlacebo comparatorParticipants will be asked to chew 2 pieces of pure gum base with no additives chewing gum 2 times a day for the same four-week period.
Receives: Dietary Supplement: Gum base with no additives

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in target species of the oral microbiome

    Total microbiome analyses will be performed at the beginning and end of the study (4 weeks) to assess total cultivable flora, levels of S. mutans, S. salivarius, and P. gingivalis in addition to using qRT-PCR from plaque and saliva samples

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2023
  2. Study startJul 2023 (estimated)
  3. Primary completionDec 2023 (estimated)
  4. Study completionApr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05946473
Sponsor's protocol ID
44196
Status last verified
Jul 2023
First submitted
6 Jul 2023
Last updated
14 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Gum base containing xylitol and essencial oils and Gum base with no additives in people with Dental Plaque and Dental Caries, run by University of Toronto.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in target species of the oral microbiome (time frame: 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in